260 related articles for article (PubMed ID: 11855850)
1. Metformin restores responses to insulin but not to growth hormone in Sprague-Dawley rats.
Borst SE; Snellen HG; Ross H; Scarpace PJ; Kim YW
Biochem Biophys Res Commun; 2002 Mar; 291(3):722-6. PubMed ID: 11855850
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of tumor necrosis factor-alpha reverses insulin resistance in skeletal muscle but not adipose tissue.
Borst SE; Lee Y; Conover CF; Shek EW; Bagby GJ
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E934-8. PubMed ID: 15213061
[TBL] [Abstract][Full Text] [Related]
3. High-fat diet induces increased tissue expression of TNF-alpha.
Borst SE; Conover CF
Life Sci; 2005 Sep; 77(17):2156-65. PubMed ID: 15935403
[TBL] [Abstract][Full Text] [Related]
4. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia.
Smith AC; Mullen KL; Junkin KA; Nickerson J; Chabowski A; Bonen A; Dyck DJ
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E172-81. PubMed ID: 17374701
[TBL] [Abstract][Full Text] [Related]
5. Adipose tumor necrosis factor-alpha is reduced during onset of insulin resistance in Sprague-Dawley rats.
Borst SE; Bagby GJ
Cytokine; 2004 Jun; 26(5):217-22. PubMed ID: 15157899
[TBL] [Abstract][Full Text] [Related]
6. Association of resistin with visceral fat and muscle insulin resistance.
Borst SE; Conover CF; Bagby GJ
Cytokine; 2005 Oct; 32(1):39-44. PubMed ID: 16154759
[TBL] [Abstract][Full Text] [Related]
7. Increased intraabdominal adipose tissue mass in fructose fed rats: correction by metformin.
Baret G; Peyronnet J; Grassi-Kassisse D; Dalmaz Y; Wiernsperger N; Géloën A
Exp Clin Endocrinol Diabetes; 2002 Sep; 110(6):298-303. PubMed ID: 12373634
[TBL] [Abstract][Full Text] [Related]
8. Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle.
Collier CA; Bruce CR; Smith AC; Lopaschuk G; Dyck DJ
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E182-9. PubMed ID: 16478780
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance.
Lessard SJ; Rivas DA; Chen ZP; Bonen A; Febbraio MA; Reeder DW; Kemp BE; Yaspelkis BB; Hawley JA
Diabetes; 2007 Jul; 56(7):1856-64. PubMed ID: 17440174
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
11. Metformin, but not exercise training, increases insulin responsiveness in skeletal muscle of Sprague-Dawley rats.
Borst SE; Snellen HG
Life Sci; 2001 Aug; 69(13):1497-507. PubMed ID: 11554611
[TBL] [Abstract][Full Text] [Related]
12. Exercise training attenuates lipectomy-induced impaired glucose tolerance in rats.
Coelho DF; Gualano B; Artioli GG; Roschel H; Amano M; Benatti FB; Fernandes T; Bueno CR; Câmara NO; Lancha AH
Endocr Regul; 2009 Jul; 43(3):107-16. PubMed ID: 19817505
[TBL] [Abstract][Full Text] [Related]
13. Comparison of tamoxifen effects on the actions of triiodothyronine or growth hormone in the ovariectomized-hypothyroid rat.
Fitts JM; Klein RM; Powers CA
J Pharmacol Exp Ther; 1998 Jul; 286(1):392-402. PubMed ID: 9655884
[TBL] [Abstract][Full Text] [Related]
14. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
[TBL] [Abstract][Full Text] [Related]
15. Effects of resistance exercise and growth hormone administration at low doses on lipid metabolism in middle-aged female rats.
Yang JY; Nam JH; Park H; Cha YS
Eur J Pharmacol; 2006 Jun; 539(1-2):99-107. PubMed ID: 16687135
[TBL] [Abstract][Full Text] [Related]
16. Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy.
Attallah H; Friedlander AL; Hoffman AR
Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S62-7. PubMed ID: 16624603
[TBL] [Abstract][Full Text] [Related]
17. Modulation of insulin resistance in ovariectomized rats by endurance exercise training and estrogen replacement.
Saengsirisuwan V; Pongseeda S; Prasannarong M; Vichaiwong K; Toskulkao C
Metabolism; 2009 Jan; 58(1):38-47. PubMed ID: 19059529
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone-induced increases in skeletal muscle mass alleviates the associated insulin resistance in short children born small for gestational age, but not with growth hormone deficiency.
Martin DD; Schweizer R; Schönau E; Binder G; Ranke MB
Horm Res; 2009; 72(1):38-45. PubMed ID: 19571558
[TBL] [Abstract][Full Text] [Related]
19. Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control.
Ahn CW; Kim CS; Nam JH; Kim HJ; Nam JS; Park JS; Kang ES; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
Clin Endocrinol (Oxf); 2006 Apr; 64(4):444-9. PubMed ID: 16584518
[TBL] [Abstract][Full Text] [Related]
20. Late but not early gestational maternal growth hormone treatment increases fetal adiposity in overnourished adolescent sheep.
Wallace JM; Matsuzaki M; Milne J; Aitken R
Biol Reprod; 2006 Aug; 75(2):231-9. PubMed ID: 16687645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
